| Literature DB >> 30931029 |
Pichanan Methajarunon1, Chachris Eitivipart2, Claire J Diver3, Anchalee Foongchomcheay2.
Abstract
BACKGROUND: Multiple sclerosis, Parkinson's disease, and hemiplegia are common disorders that directly cause impairment of balance and gait. Aquatic exercises are used for neurological rehabilitation. It is suggested that the contributing factors of the water setting such as buoyancy, viscosity, and hydrostatic pressure offer an ideal environment for rehabilitative programmes.Entities:
Keywords: Parkinson’s disease; aquatic exercise; balance; hemiplegia; multiple sclerosis
Year: 2016 PMID: 30931029 PMCID: PMC6385144 DOI: 10.1016/j.hkpj.2016.03.002
Source DB: PubMed Journal: Hong Kong Physiother J ISSN: 1013-7025
Figure 1.Flow chart for the selection of studies.
Characteristics of aquatic exercise programmes and measurements of outcome included in the review.
| Reference | Design | Type of participants ( | Dropouts (E/C) | Mean age (y) (E/C) | Interventions | Dosage | Duration (wk) | Method of balance-gait measurements | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min/session | Time/wk | |||||||||||
| Bayraktar et al | QES | MS (23) | 5 (4/1) | 38/39 | 60 | 2 | 8 | TUG 6MWT 1LST | ||||
| Marandi et al | QES | MS (57) | 12 (4/4/4) | Not reported | 60 | 3 | 12 | SSST | ||||
| Salem et al | QES | MS (11) | 1 | 55.9 | 60 | 2 | 5 | BBS TUG 10-m walk | ||||
| Jacobs et al | QES | PD (8) | 0 | 67.75 | 60 | 2 | 6 | BBS STS step test | ||||
| Vivas et al | RCT | PD (12) | 1 (1/0) | 65.67/68.33 | 45 | 2 | 4 | BBS TUG FRT 5-m walk | ||||
| Jung et al | RCT | HEMI (30) | 0 | 57.2/55.6 | 40 | 3 | 12 | Sway of centre of pressure with EC | ||||
| Park and Roh | RCT | HEMI (46) | 0 | 54.6/56.6 | 35 | 6 | 6 | Sway of centre of pressure with EO and EC | ||||
| Lee et al | RCT | HEMI (34) | 0 | 62.1/61.4 | 50 | 3 | 12 | Sway of centre of pressure with EO and EC | ||||
10-m walk = 10-meter walk test; 1LST = one-leg standing test; 5-m walk = 5-minute walk test; 6MWT = 6-minute walk test; BBS = Berg Balance Scale; E/C = experimental group versus control group; EC = eye closed; EO = eye open; FRT = functional reach test; HEMI = hemiparesis; MS = multiple sclerosis; N = number; PD = Parkinson’s disease; QES = quasi-experimental study; RCT = randomized-controlled trial; SSST = six-spot step test; STS = sit-to-stand task; TUG = Timed Up and Go Test.
An assessment of the methodological quality of studies assessed by the Downs and Black checklist.
| Checklist | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | |
| Study aim | Main outcome | Participant characteristics | Description of intervention | Principal confounders | Outcome data | Range of results | Adverse events | Lost to follow-up | Probability value (exact) | Source population | Representative of population | Staff, place, facility | Participants blind to intervention | Blind assessors | Data dredging | Same length of follow-up | Appropriate statistical tests | Compliance with the intervention | Accurate outcome measure | Control recruited same | Recruitment at same time | Randomized allocation | Concealed randomization | Adjustment for confounders | Participants lost to follow-up | Power | Total | |
| Bayraktar et al | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | U | U | N | N | Y | Y | Y | Y | U | Y | Y | U | N | N | Y | N | 0 | 18/29 |
| Marandi et al | N | Y | N | Y | N | Y | Y | N | Y | N | U | U | U | N | U | Y | Y | Y | U | Y | Y | U | Y | N | N | U | 2 | 13/29 |
| Salem et al | Y | Y | Y | Y | P | Y | Y | Y | Y | Y | U | U | Y | N | U | Y | Y | Y | Y | Y | Y | U | N | N | N | Y | 0 | 18/29 |
| Jacobs et al | Y | Y | Y | Y | P | Y | N | Y | Y | Y | U | U | Y | N | N | Y | Y | Y | Y | Y | N | U | N | N | N | Y | 0 | 16/29 |
| Vivas et al | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | U | U | Y | N | N | Y | Y | Y | Y | Y | Y | U | Y | U | Y | Y | 0 | 20/29 |
| Jung et al | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | N | N | U | U | U | Y | Y | Y | Y | Y | Y | U | Y | U | Y | Y | 0 | 19/29 |
| Park and Roh | Y | Y | Y | Y | Y | Y | Y | N | Y | N | U | U | Y | U | U | Y | Y | Y | Y | Y | Y | U | Y | U | Y | U | 0 | 18/29 |
| Lee et al | Y | Y | Y | Y | Y | Y | Y | N | Y | N | U | U | U | N | U | Y | Y | Y | Y | Y | Y | U | Y | U | Y | Y | 0 | 18/29 |
N = answer is no; P = partial answer; U = unable to determine; Y = answer is yes.
All questions except Question Numbers 5 and 27 will assign a score of “0” if the answer is “no” or “unable to determine,” and “1” if the answer is “yes.” The total quality scores of studies are as follows: less than 11 = poor; 11–19 = fair; greater than 19 = good.
Items 1–27 of the Downs and Black checklist.
Question Number 5 will assign a score of “0” if the answer is “no,” “1” if the answer is “partial,” and “2” if the answer is “yes”.
Question Number 27 will assign a score of “0” if no power calculation is provided, “1” if a power calculation is provided but the importance or impact of the difference between groups used in the calculation is unclear, and “2” if the difference between groups is clearly defined as a clinically important difference.